サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1374432

ガラス固化の世界市場規模、シェア、産業動向分析レポート：検体別、最終用途別、地域別展望と予測、2023年～2030年

Global Vitrification Market Size, Share & Industry Trends Analysis Report By Specimen (Oocytes (Devices, Kits & Consumables), Embryo (Devices, Kits & Consumables), and Sperm), By End-use, By Regional Outlook and Forecast, 2023 - 2030

出版日
発行
KBV Research
ページ情報
英文 231 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
ガラス固化の世界市場規模、シェア、産業動向分析レポート：検体別、最終用途別、地域別展望と予測、2023年～2030年
出版日: 2023年09月30日
発行: KBV Research
ページ情報: 英文 231 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ガラス固化市場規模は2030年までに241億米ドルに達し、予測期間中のCAGRは17.2％の市場成長率で上昇すると予測されています。

しかし、自然に任せていたら存在し得ない生命を人工的に作り出すという考えを嫌う人もいます。また、「自然淘汰」に任せるべきだという意見もあります。一夫一婦制の結婚制度と人間の生命の尊厳は、どちらも体外受精によって影響を受ける。受精した子供にとっては、アイデンティティの問題も生じる。受胎から始まる最も初期の段階においても、人間の生命には計り知れない意味があります。社会とヘルスケア専門家に影響を与えうる法的問題には、医療過誤の疑い、未成年である患者からのインフォームド・コンセント、法的親権などがあります。体外受精と妊孕性温存に関するこうした倫理的・技術的問題は、市場の拡大を妨げる可能性があります。

さらに、COVID-19パンデミックは世界経済に大きな影響を及ぼしたが、ヘルスケア業界もこの影響を免れなかっています。パンデミックは市場に悪影響を与えました。国際的な不妊治療協会は、世界保健機関（WHO）のCOVID-19パンデミックの間、必要な医療的妊孕性温存を除き、体外受精治療を継続しないよう勧告しました。しかし、COVID-19の制限が緩和されたことで、IVFクリニックやその他の医療施設は、十分なスタッフの確保や適切な安全手順の遵守などの予防措置を講じた上で再開することができました。こうした要素が、パンデミック後の市場の早期回復につながっています。

検体の見通し

検体別では、市場は卵子、胚、精子に区分されます。2022年には、胚セグメントが市場でかなりの収益シェアを獲得しました。余分な胚は保存のためにガラス化されます。体外受精の実践者は、多胎妊娠の可能性を減らすために、子宮に少ない新鮮胚を転送します。凍結胚移植は、最初のサイクルが失敗した場合、卵巣刺激と採卵の不便さを再度経験するよりもむしろ実行されるかもしれません。

卵母細胞の展望

卵母細胞セグメントは、さらにデバイスとキット＆消耗品に細分化されます。キットおよび消耗品セグメントは、2022年の市場で大きな収益シェアを獲得しました。妊孕性温存とARTにおける卵子ガラス固化の成功は、使用する材料と手順の品質に依存します。ガラス固化キットと消耗品は、卵子が高い生存率と発育可能性をもって保存されることを保証し、この技術の全体的な成功率に大きく貢献しています。

胚の展望

胚セグメントはさらにデバイスとキット＆消耗品に二分されます。2022年の市場では、デバイス分野が最大の収益シェアを獲得しました。ストロー、バイアル、または特殊な容器などのガラス固化デバイスは、胚の保護エンクロージャとして機能します。それらは、凍結保護液に直接さらされるのを防ぎ、物理的損傷のリスクを最小限に抑えながら、ガラス化プロセス中に胚を安全に封じ込めます。デバイスは、ガラス化溶液と胚の特定の容量を保持するように設計されています。

最終用途の展望

最終用途に基づき、市場はIVFクリニックとバイオバンクに細分化されます。2022年には、IVFクリニック部門が市場で最大の収益シェアを占めました。ガラス固化やその他のARTサービスを提供するIVFクリニックの数が増加していることが、大きな収益シェアにつながっている可能性があります。さらに、クリニックは精子、卵子、卵母細胞の保存のようなサービスを提供しており、クリニックの収入シェアを増加させると予想されます。体外受精の進捗率や卵子・胚の凍結サイクル数に関して、ガラス固化技術は生殖医療環境を大幅に向上させる。

地域別展望

地域別では、市場は北米、欧州、アジア太平洋、LAMEAで分析されます。2022年には、欧州地域が最大の収益シェアを獲得して市場をリードしました。フランス、スペイン、ドイツ、英国、イタリアなどの新興経済諸国がこの原因です。これらの国ではインフラが発達しているため、凍結保存技術はこの地域で劇的に増加すると予想されます。さらに、英国やドイツのような国々では、バイオテクノロジー部門の拡大と生殖補助医療技術の市場開拓に対する財政支援が市場成長に寄与しています。不妊症の罹患率の高さと卵子保存に対する女性の関心の高まりが、地域開発の主な促進要因です。

目次

第1章 市場範囲と調査手法

  • 市場の定義
  • 目的
  • 市場範囲
  • セグメンテーション
  • 調査手法

第2章 市場の概要

  • 主なハイライト

第3章 市場概要

  • イントロダクション
    • 概要
      • 市場構成とシナリオ
  • 市場に影響を与える主な要因
    • 市場促進要因
    • 市場抑制要因
  • ポーターファイブフォース分析

第4章 世界のガラス固化市場標本ごと

  • 世界の卵子市場：地域別
  • 世界のガラス固化市場：卵子の種類別
    • 世界のデバイス市場：地域別
    • 世界のキットおよび消耗品市場：地域別
  • 世界の胚市場：地域別
  • 世界のガラス固化市場：胚の種類別
    • 世界のデバイス市場：地域別
    • 世界のキットおよび消耗品市場：地域別
  • 世界の精子市場：地域別

第5章 世界の市場：、最終用途別

  • 世界の体外受精クリニック市場：地域別
  • 世界のバイオバンク市場：地域別

第6章 世界の市場：、地域別

  • 北米の市場
    • 北米の市場標本別
      • 国別の北米卵子市場
      • 北米の市場：卵子の種類別
      • 北米の国別胚市場
      • 北米の市場：胚の種類別
      • 国別の北米精子市場
    • 北米の市場：最終用途別
      • 北米の国別体外受精クリニック市場
      • 国別の北米バイオバンク市場
    • 北米の市場：国別
      • 米国のガラス固化市場
      • カナダのガラス固化市場
      • メキシコのガラス固化市場
      • 残りの北米の市場
  • 欧州の市場
    • 欧州の市場標本別
      • 欧州の国別卵子市場
      • 欧州の市場：卵子の種類別
      • 欧州の国別胚市場
      • 欧州の市場：胚の種類別
      • 欧州の国別精子市場
    • 欧州の市場：最終用途別
      • 欧州の国別体外受精クリニック市場
      • 国別の欧州バイオバンク市場
    • 欧州の市場：国別
      • ドイツのガラス固化市場
      • 英国のガラス固化市場
      • フランスのガラス固化市場
      • ロシアのガラス固化市場
      • スペインのガラス固化市場
      • イタリアのガラス固化市場
      • 残りの欧州の市場
  • アジア太平洋の市場
    • アジア太平洋の市場標本別
      • アジア太平洋地域の国別卵子市場
      • アジア太平洋の市場：卵子の種類別
      • アジア太平洋地域の国別胚市場
      • アジア太平洋の市場：胚の種類別
      • アジア太平洋地域の国別精子市場
    • アジア太平洋の市場：最終用途別
      • アジア太平洋地域の国別体外受精クリニック市場
      • 国別のアジア太平洋バイオバンク市場
    • アジア太平洋の市場：国別
      • 中国ガラス固化市場
      • 日本のガラス固化市場
      • インドのガラス固化市場
      • 韓国のガラス固化市場
      • シンガポールのガラス固化市場
      • マレーシアのガラス固化市場
      • 残りのアジア太平洋の市場
  • ラテンアメリカ・中東・アフリカの市場
    • ラテンアメリカ・中東・アフリカの市場標本別
      • 国別のLAMEA卵子市場
      • ラテンアメリカ・中東・アフリカの市場：卵子の種類別
      • 国別LAMEA胚市場
      • ラテンアメリカ・中東・アフリカの市場：胚の種類別
      • 国別LAMEA精子市場
    • ラテンアメリカ・中東・アフリカの市場：最終用途別
      • 国別のLAMEA IVFクリニック市場
      • 国別のLAMEAバイオバンク市場
    • ラテンアメリカ・中東・アフリカの市場：国別
      • ブラジルのガラス固化市場
      • アルゼンチンのガラス固化市場
      • UAEのガラス固化市場
      • サウジアラビアのガラス固化市場
      • 南アフリカのガラス固化市場
      • ナイジェリアのガラス固化市場
      • 残りのラテンアメリカ・中東・アフリカの市場

第7章 企業プロファイル

  • Vitrolife AB
  • Genea Limited（Liverpool Partners Group）
  • NidaCon International AB
  • Minitub GmbH
  • Cryo Bio System（IMV Technologies Group）
  • CooperSurgical Fertility & Genomic Solutions（The Cooper Companies, Inc）
  • FUJIFILM Irvine Scientific, Inc（Fujifilm Holdings Corporation）
  • Biotech, Inc
  • Kitazato Corporation
  • Shenzhen VitaVitro Biotech

第8章 勝利の必須事項：

図表

LIST OF TABLES

  • TABLE 1 Global Vitrification Market, 2019 - 2022, USD Million
  • TABLE 2 Global Vitrification Market, 2023 - 2030, USD Million
  • TABLE 3 Global Vitrification Market, By Specimen, 2019 - 2022, USD Million
  • TABLE 4 Global Vitrification Market, By Specimen, 2023 - 2030, USD Million
  • TABLE 5 Global Oocytes Market, By Region, 2019 - 2022, USD Million
  • TABLE 6 Global Oocytes Market, By Region, 2023 - 2030, USD Million
  • TABLE 7 Global Vitrification Market, By Oocytes Type, 2019 - 2022, USD Million
  • TABLE 8 Global Vitrification Market, By Oocytes Type, 2023 - 2030, USD Million
  • TABLE 9 Global Devices Market, By Region, 2019 - 2022, USD Million
  • TABLE 10 Global Devices Market, By Region, 2023 - 2030, USD Million
  • TABLE 11 Global Kits & Consumables Market, By Region, 2019 - 2022, USD Million
  • TABLE 12 Global Kits & Consumables Market, By Region, 2023 - 2030, USD Million
  • TABLE 13 Global Embryo Market, By Region, 2019 - 2022, USD Million
  • TABLE 14 Global Embryo Market, By Region, 2023 - 2030, USD Million
  • TABLE 15 Global Vitrification Market, By Embryo Type, 2019 - 2022, USD Million
  • TABLE 16 Global Vitrification Market, By Embryo Type, 2023 - 2030, USD Million
  • TABLE 17 Global Devices Market, By Region, 2019 - 2022, USD Million
  • TABLE 18 Global Devices Market, By Region, 2023 - 2030, USD Million
  • TABLE 19 Global Kits & Consumables Market, By Region, 2019 - 2022, USD Million
  • TABLE 20 Global Kits & Consumables Market, By Region, 2023 - 2030, USD Million
  • TABLE 21 Global Sperm Market, By Region, 2019 - 2022, USD Million
  • TABLE 22 Global Sperm Market, By Region, 2023 - 2030, USD Million
  • TABLE 23 Global Vitrification Market, By End-use, 2019 - 2022, USD Million
  • TABLE 24 Global Vitrification Market, By End-use, 2023 - 2030, USD Million
  • TABLE 25 Global IVF Clinics Market, By Region, 2019 - 2022, USD Million
  • TABLE 26 Global IVF Clinics Market, By Region, 2023 - 2030, USD Million
  • TABLE 27 Global Biobanks Market, By Region, 2019 - 2022, USD Million
  • TABLE 28 Global Biobanks Market, By Region, 2023 - 2030, USD Million
  • TABLE 29 Global Vitrification Market, By Region, 2019 - 2022, USD Million
  • TABLE 30 Global Vitrification Market, By Region, 2023 - 2030, USD Million
  • TABLE 31 North America Vitrification Market, 2019 - 2022, USD Million
  • TABLE 32 North America Vitrification Market, 2023 - 2030, USD Million
  • TABLE 33 North America Vitrification Market, By Specimen, 2019 - 2022, USD Million
  • TABLE 34 North America Vitrification Market, By Specimen, 2023 - 2030, USD Million
  • TABLE 35 North America Oocytes Market, By Country, 2019 - 2022, USD Million
  • TABLE 36 North America Oocytes Market, By Country, 2023 - 2030, USD Million
  • TABLE 37 North America Vitrification Market, By Oocytes Type, 2019 - 2022, USD Million
  • TABLE 38 North America Vitrification Market, By Oocytes Type, 2023 - 2030, USD Million
  • TABLE 39 North America Devices Market, By Country, 2019 - 2022, USD Million
  • TABLE 40 North America Devices Market, By Country, 2023 - 2030, USD Million
  • TABLE 41 North America Kits & Consumables Market, By Country, 2019 - 2022, USD Million
  • TABLE 42 North America Kits & Consumables Market, By Country, 2023 - 2030, USD Million
  • TABLE 43 North America Embryo Market, By Country, 2019 - 2022, USD Million
  • TABLE 44 North America Embryo Market, By Country, 2023 - 2030, USD Million
  • TABLE 45 North America Vitrification Market, By Embryo Type, 2019 - 2022, USD Million
  • TABLE 46 North America Vitrification Market, By Embryo Type, 2023 - 2030, USD Million
  • TABLE 47 North America Devices Market, By Country, 2019 - 2022, USD Million
  • TABLE 48 North America Devices Market, By Country, 2023 - 2030, USD Million
  • TABLE 49 North America Kits & Consumables Market, By Country, 2019 - 2022, USD Million
  • TABLE 50 North America Kits & Consumables Market, By Country, 2023 - 2030, USD Million
  • TABLE 51 North America Sperm Market, By Country, 2019 - 2022, USD Million
  • TABLE 52 North America Sperm Market, By Country, 2023 - 2030, USD Million
  • TABLE 53 North America Vitrification Market, By End-use, 2019 - 2022, USD Million
  • TABLE 54 North America Vitrification Market, By End-use, 2023 - 2030, USD Million
  • TABLE 55 North America IVF Clinics Market, By Country, 2019 - 2022, USD Million
  • TABLE 56 North America IVF Clinics Market, By Country, 2023 - 2030, USD Million
  • TABLE 57 North America Biobanks Market, By Country, 2019 - 2022, USD Million
  • TABLE 58 North America Biobanks Market, By Country, 2023 - 2030, USD Million
  • TABLE 59 North America Vitrification Market, By Country, 2019 - 2022, USD Million
  • TABLE 60 North America Vitrification Market, By Country, 2023 - 2030, USD Million
  • TABLE 61 US Vitrification Market, 2019 - 2022, USD Million
  • TABLE 62 US Vitrification Market, 2023 - 2030, USD Million
  • TABLE 63 US Vitrification Market, By Specimen, 2019 - 2022, USD Million
  • TABLE 64 US Vitrification Market, By Specimen, 2023 - 2030, USD Million
  • TABLE 65 US Vitrification Market, By Oocytes Type, 2019 - 2022, USD Million
  • TABLE 66 US Vitrification Market, By Oocytes Type, 2023 - 2030, USD Million
  • TABLE 67 US Vitrification Market, By Embryo Type, 2019 - 2022, USD Million
  • TABLE 68 US Vitrification Market, By Embryo Type, 2023 - 2030, USD Million
  • TABLE 69 US Vitrification Market, By End-use, 2019 - 2022, USD Million
  • TABLE 70 US Vitrification Market, By End-use, 2023 - 2030, USD Million
  • TABLE 71 Canada Vitrification Market, 2019 - 2022, USD Million
  • TABLE 72 Canada Vitrification Market, 2023 - 2030, USD Million
  • TABLE 73 Canada Vitrification Market, By Specimen, 2019 - 2022, USD Million
  • TABLE 74 Canada Vitrification Market, By Specimen, 2023 - 2030, USD Million
  • TABLE 75 Canada Vitrification Market, By Oocytes Type, 2019 - 2022, USD Million
  • TABLE 76 Canada Vitrification Market, By Oocytes Type, 2023 - 2030, USD Million
  • TABLE 77 Canada Vitrification Market, By Embryo Type, 2019 - 2022, USD Million
  • TABLE 78 Canada Vitrification Market, By Embryo Type, 2023 - 2030, USD Million
  • TABLE 79 Canada Vitrification Market, By End-use, 2019 - 2022, USD Million
  • TABLE 80 Canada Vitrification Market, By End-use, 2023 - 2030, USD Million
  • TABLE 81 Mexico Vitrification Market, 2019 - 2022, USD Million
  • TABLE 82 Mexico Vitrification Market, 2023 - 2030, USD Million
  • TABLE 83 Mexico Vitrification Market, By Specimen, 2019 - 2022, USD Million
  • TABLE 84 Mexico Vitrification Market, By Specimen, 2023 - 2030, USD Million
  • TABLE 85 Mexico Vitrification Market, By Oocytes Type, 2019 - 2022, USD Million
  • TABLE 86 Mexico Vitrification Market, By Oocytes Type, 2023 - 2030, USD Million
  • TABLE 87 Mexico Vitrification Market, By Embryo Type, 2019 - 2022, USD Million
  • TABLE 88 Mexico Vitrification Market, By Embryo Type, 2023 - 2030, USD Million
  • TABLE 89 Mexico Vitrification Market, By End-use, 2019 - 2022, USD Million
  • TABLE 90 Mexico Vitrification Market, By End-use, 2023 - 2030, USD Million
  • TABLE 91 Rest of North America Vitrification Market, 2019 - 2022, USD Million
  • TABLE 92 Rest of North America Vitrification Market, 2023 - 2030, USD Million
  • TABLE 93 Rest of North America Vitrification Market, By Specimen, 2019 - 2022, USD Million
  • TABLE 94 Rest of North America Vitrification Market, By Specimen, 2023 - 2030, USD Million
  • TABLE 95 Rest of North America Vitrification Market, By Oocytes Type, 2019 - 2022, USD Million
  • TABLE 96 Rest of North America Vitrification Market, By Oocytes Type, 2023 - 2030, USD Million
  • TABLE 97 Rest of North America Vitrification Market, By Embryo Type, 2019 - 2022, USD Million
  • TABLE 98 Rest of North America Vitrification Market, By Embryo Type, 2023 - 2030, USD Million
  • TABLE 99 Rest of North America Vitrification Market, By End-use, 2019 - 2022, USD Million
  • TABLE 100 Rest of North America Vitrification Market, By End-use, 2023 - 2030, USD Million
  • TABLE 101 Europe Vitrification Market, 2019 - 2022, USD Million
  • TABLE 102 Europe Vitrification Market, 2023 - 2030, USD Million
  • TABLE 103 Europe Vitrification Market, By Specimen, 2019 - 2022, USD Million
  • TABLE 104 Europe Vitrification Market, By Specimen, 2023 - 2030, USD Million
  • TABLE 105 Europe Oocytes Market, By Country, 2019 - 2022, USD Million
  • TABLE 106 Europe Oocytes Market, By Country, 2023 - 2030, USD Million
  • TABLE 107 Europe Vitrification Market, By Oocytes Type, 2019 - 2022, USD Million
  • TABLE 108 Europe Vitrification Market, By Oocytes Type, 2023 - 2030, USD Million
  • TABLE 109 Europe Devices Market, By Country, 2019 - 2022, USD Million
  • TABLE 110 Europe Devices Market, By Country, 2023 - 2030, USD Million
  • TABLE 111 Europe Kits & Consumables Market, By Country, 2019 - 2022, USD Million
  • TABLE 112 Europe Kits & Consumables Market, By Country, 2023 - 2030, USD Million
  • TABLE 113 Europe Embryo Market, By Country, 2019 - 2022, USD Million
  • TABLE 114 Europe Embryo Market, By Country, 2023 - 2030, USD Million
  • TABLE 115 Europe Vitrification Market, By Embryo Type, 2019 - 2022, USD Million
  • TABLE 116 Europe Vitrification Market, By Embryo Type, 2023 - 2030, USD Million
  • TABLE 117 Europe Devices Market, By Country, 2019 - 2022, USD Million
  • TABLE 118 Europe Devices Market, By Country, 2023 - 2030, USD Million
  • TABLE 119 Europe Kits & Consumables Market, By Country, 2019 - 2022, USD Million
  • TABLE 120 Europe Kits & Consumables Market, By Country, 2023 - 2030, USD Million
  • TABLE 121 Europe Sperm Market, By Country, 2019 - 2022, USD Million
  • TABLE 122 Europe Sperm Market, By Country, 2023 - 2030, USD Million
  • TABLE 123 Europe Vitrification Market, By End-use, 2019 - 2022, USD Million
  • TABLE 124 Europe Vitrification Market, By End-use, 2023 - 2030, USD Million
  • TABLE 125 Europe IVF Clinics Market, By Country, 2019 - 2022, USD Million
  • TABLE 126 Europe IVF Clinics Market, By Country, 2023 - 2030, USD Million
  • TABLE 127 Europe Biobanks Market, By Country, 2019 - 2022, USD Million
  • TABLE 128 Europe Biobanks Market, By Country, 2023 - 2030, USD Million
  • TABLE 129 Europe Vitrification Market, By Country, 2019 - 2022, USD Million
  • TABLE 130 Europe Vitrification Market, By Country, 2023 - 2030, USD Million
  • TABLE 131 Germany Vitrification Market, 2019 - 2022, USD Million
  • TABLE 132 Germany Vitrification Market, 2023 - 2030, USD Million
  • TABLE 133 Germany Vitrification Market, By Specimen, 2019 - 2022, USD Million
  • TABLE 134 Germany Vitrification Market, By Specimen, 2023 - 2030, USD Million
  • TABLE 135 Germany Vitrification Market, By Oocytes Type, 2019 - 2022, USD Million
  • TABLE 136 Germany Vitrification Market, By Oocytes Type, 2023 - 2030, USD Million
  • TABLE 137 Germany Vitrification Market, By Embryo Type, 2019 - 2022, USD Million
  • TABLE 138 Germany Vitrification Market, By Embryo Type, 2023 - 2030, USD Million
  • TABLE 139 Germany Vitrification Market, By End-use, 2019 - 2022, USD Million
  • TABLE 140 Germany Vitrification Market, By End-use, 2023 - 2030, USD Million
  • TABLE 141 UK Vitrification Market, 2019 - 2022, USD Million
  • TABLE 142 UK Vitrification Market, 2023 - 2030, USD Million
  • TABLE 143 UK Vitrification Market, By Specimen, 2019 - 2022, USD Million
  • TABLE 144 UK Vitrification Market, By Specimen, 2023 - 2030, USD Million
  • TABLE 145 UK Vitrification Market, By Oocytes Type, 2019 - 2022, USD Million
  • TABLE 146 UK Vitrification Market, By Oocytes Type, 2023 - 2030, USD Million
  • TABLE 147 UK Vitrification Market, By Embryo Type, 2019 - 2022, USD Million
  • TABLE 148 UK Vitrification Market, By Embryo Type, 2023 - 2030, USD Million
  • TABLE 149 UK Vitrification Market, By End-use, 2019 - 2022, USD Million
  • TABLE 150 UK Vitrification Market, By End-use, 2023 - 2030, USD Million
  • TABLE 151 France Vitrification Market, 2019 - 2022, USD Million
  • TABLE 152 France Vitrification Market, 2023 - 2030, USD Million
  • TABLE 153 France Vitrification Market, By Specimen, 2019 - 2022, USD Million
  • TABLE 154 France Vitrification Market, By Specimen, 2023 - 2030, USD Million
  • TABLE 155 France Vitrification Market, By Oocytes Type, 2019 - 2022, USD Million
  • TABLE 156 France Vitrification Market, By Oocytes Type, 2023 - 2030, USD Million
  • TABLE 157 France Vitrification Market, By Embryo Type, 2019 - 2022, USD Million
  • TABLE 158 France Vitrification Market, By Embryo Type, 2023 - 2030, USD Million
  • TABLE 159 France Vitrification Market, By End-use, 2019 - 2022, USD Million
  • TABLE 160 France Vitrification Market, By End-use, 2023 - 2030, USD Million
  • TABLE 161 Russia Vitrification Market, 2019 - 2022, USD Million
  • TABLE 162 Russia Vitrification Market, 2023 - 2030, USD Million
  • TABLE 163 Russia Vitrification Market, By Specimen, 2019 - 2022, USD Million
  • TABLE 164 Russia Vitrification Market, By Specimen, 2023 - 2030, USD Million
  • TABLE 165 Russia Vitrification Market, By Oocytes Type, 2019 - 2022, USD Million
  • TABLE 166 Russia Vitrification Market, By Oocytes Type, 2023 - 2030, USD Million
  • TABLE 167 Russia Vitrification Market, By Embryo Type, 2019 - 2022, USD Million
  • TABLE 168 Russia Vitrification Market, By Embryo Type, 2023 - 2030, USD Million
  • TABLE 169 Russia Vitrification Market, By End-use, 2019 - 2022, USD Million
  • TABLE 170 Russia Vitrification Market, By End-use, 2023 - 2030, USD Million
  • TABLE 171 Spain Vitrification Market, 2019 - 2022, USD Million
  • TABLE 172 Spain Vitrification Market, 2023 - 2030, USD Million
  • TABLE 173 Spain Vitrification Market, By Specimen, 2019 - 2022, USD Million
  • TABLE 174 Spain Vitrification Market, By Specimen, 2023 - 2030, USD Million
  • TABLE 175 Spain Vitrification Market, By Oocytes Type, 2019 - 2022, USD Million
  • TABLE 176 Spain Vitrification Market, By Oocytes Type, 2023 - 2030, USD Million
  • TABLE 177 Spain Vitrification Market, By Embryo Type, 2019 - 2022, USD Million
  • TABLE 178 Spain Vitrification Market, By Embryo Type, 2023 - 2030, USD Million
  • TABLE 179 Spain Vitrification Market, By End-use, 2019 - 2022, USD Million
  • TABLE 180 Spain Vitrification Market, By End-use, 2023 - 2030, USD Million
  • TABLE 181 Italy Vitrification Market, 2019 - 2022, USD Million
  • TABLE 182 Italy Vitrification Market, 2023 - 2030, USD Million
  • TABLE 183 Italy Vitrification Market, By Specimen, 2019 - 2022, USD Million
  • TABLE 184 Italy Vitrification Market, By Specimen, 2023 - 2030, USD Million
  • TABLE 185 Italy Vitrification Market, By Oocytes Type, 2019 - 2022, USD Million
  • TABLE 186 Italy Vitrification Market, By Oocytes Type, 2023 - 2030, USD Million
  • TABLE 187 Italy Vitrification Market, By Embryo Type, 2019 - 2022, USD Million
  • TABLE 188 Italy Vitrification Market, By Embryo Type, 2023 - 2030, USD Million
  • TABLE 189 Italy Vitrification Market, By End-use, 2019 - 2022, USD Million
  • TABLE 190 Italy Vitrification Market, By End-use, 2023 - 2030, USD Million
  • TABLE 191 Rest of Europe Vitrification Market, 2019 - 2022, USD Million
  • TABLE 192 Rest of Europe Vitrification Market, 2023 - 2030, USD Million
  • TABLE 193 Rest of Europe Vitrification Market, By Specimen, 2019 - 2022, USD Million
  • TABLE 194 Rest of Europe Vitrification Market, By Specimen, 2023 - 2030, USD Million
  • TABLE 195 Rest of Europe Vitrification Market, By Oocytes Type, 2019 - 2022, USD Million
  • TABLE 196 Rest of Europe Vitrification Market, By Oocytes Type, 2023 - 2030, USD Million
  • TABLE 197 Rest of Europe Vitrification Market, By Embryo Type, 2019 - 2022, USD Million
  • TABLE 198 Rest of Europe Vitrification Market, By Embryo Type, 2023 - 2030, USD Million
  • TABLE 199 Rest of Europe Vitrification Market, By End-use, 2019 - 2022, USD Million
  • TABLE 200 Rest of Europe Vitrification Market, By End-use, 2023 - 2030, USD Million
  • TABLE 201 Asia Pacific Vitrification Market, 2019 - 2022, USD Million
  • TABLE 202 Asia Pacific Vitrification Market, 2023 - 2030, USD Million
  • TABLE 203 Asia Pacific Vitrification Market, By Specimen, 2019 - 2022, USD Million
  • TABLE 204 Asia Pacific Vitrification Market, By Specimen, 2023 - 2030, USD Million
  • TABLE 205 Asia Pacific Oocytes Market, By Country, 2019 - 2022, USD Million
  • TABLE 206 Asia Pacific Oocytes Market, By Country, 2023 - 2030, USD Million
  • TABLE 207 Asia Pacific Vitrification Market, By Oocytes Type, 2019 - 2022, USD Million
  • TABLE 208 Asia Pacific Vitrification Market, By Oocytes Type, 2023 - 2030, USD Million
  • TABLE 209 Asia Pacific Devices Market, By Country, 2019 - 2022, USD Million
  • TABLE 210 Asia Pacific Devices Market, By Country, 2023 - 2030, USD Million
  • TABLE 211 Asia Pacific Kits & Consumables Market, By Country, 2019 - 2022, USD Million
  • TABLE 212 Asia Pacific Kits & Consumables Market, By Country, 2023 - 2030, USD Million
  • TABLE 213 Asia Pacific Embryo Market, By Country, 2019 - 2022, USD Million
  • TABLE 214 Asia Pacific Embryo Market, By Country, 2023 - 2030, USD Million
  • TABLE 215 Asia Pacific Vitrification Market, By Embryo Type, 2019 - 2022, USD Million
  • TABLE 216 Asia Pacific Vitrification Market, By Embryo Type, 2023 - 2030, USD Million
  • TABLE 217 Asia Pacific Devices Market, By Country, 2019 - 2022, USD Million
  • TABLE 218 Asia Pacific Devices Market, By Country, 2023 - 2030, USD Million
  • TABLE 219 Asia Pacific Kits & Consumables Market, By Country, 2019 - 2022, USD Million
  • TABLE 220 Asia Pacific Kits & Consumables Market, By Country, 2023 - 2030, USD Million
  • TABLE 221 Asia Pacific Sperm Market, By Country, 2019 - 2022, USD Million
  • TABLE 222 Asia Pacific Sperm Market, By Country, 2023 - 2030, USD Million
  • TABLE 223 Asia Pacific Vitrification Market, By End-use, 2019 - 2022, USD Million
  • TABLE 224 Asia Pacific Vitrification Market, By End-use, 2023 - 2030, USD Million
  • TABLE 225 Asia Pacific IVF Clinics Market, By Country, 2019 - 2022, USD Million
  • TABLE 226 Asia Pacific IVF Clinics Market, By Country, 2023 - 2030, USD Million
  • TABLE 227 Asia Pacific Biobanks Market, By Country, 2019 - 2022, USD Million
  • TABLE 228 Asia Pacific Biobanks Market, By Country, 2023 - 2030, USD Million
  • TABLE 229 Asia Pacific Vitrification Market, By Country, 2019 - 2022, USD Million
  • TABLE 230 Asia Pacific Vitrification Market, By Country, 2023 - 2030, USD Million
目次

The Global Vitrification Market size is expected to reach $24.1 billion by 2030, rising at a market growth of 17.2% CAGR during the forecast period.

Male fertility preservation and sperm cryopreservation are both crucial components of ART. It can help individuals with azoospermia or oligozoospermia avoid recurrent biopsies. Thus, the sperm segment will capture 1/5th share in the revenue by the year 2030. Before having chemotherapy or radiation therapy, cancer patients can also use this procedure to maintain their fertility. The standard freezing approach can achieve an adequate survival rate since mature sperm have a significant number and little volume and also tolerate freezing temperatures well. Some of the factors impacting the market are growing demand for organ transplants, rising percentage of first-time mothers at an older median age and ethical, and technical issues with IVF and fertility preservation.

Various reasons, such as pointless injury, poisoning, blood loss, drug abuse, etc., can cause organ failure. The rising incidence of renal disease, excessive alcohol use, and poor diet have pushed the growth of organ transplantation. Growing global organ donation also influences people's attitudes toward organ transplantation. By transforming them into a glass-like condition, vitrification enables the conservation of organs at extremely low temperatures (-196°C or -320°F). This makes it possible to store organs for a long time-possibly from hours to days-without any actual degradation. Additionally, over time, there has been a sharp increase in the median age of first-time mothers globally. More effective contraceptive methods, later marriages, and an increase in women prioritizing their careers over having children are the leading causes of this trend. Because of this, it is projected that as the average age of first-time mothers increases, more women will experience trouble conceiving naturally. More women are being forced to seek IVF treatments in this situation. The market is, therefore, anticipated to grow along with the rise in demand for organ transplants.

However, some individuals dislike the idea of artificially created life that couldn't exist if nature were left to itself. Another argument they can raise is that "natural selection" should be allowed to carry out its task. The institution of monogamous marriage and the sanctity of human life are both affected by in vitro fertilization. For the children who are conceived, it also raises issues with identity. Even in its earliest phases, starting with conception, human life has immense significance. Legal issues that could affect society and healthcare professionals include allegations of medical malpractice, informed consent from patients who are minors, and legal parentage. These ethical and technical issues with IVF and fertility preservation may hinder the market's expansion.

Additionally, the COVID-19 pandemic had a significant effect on the global economy; the healthcare industry was not exempted from this. The pandemic had a negative impact on the market. International fertility associations advised against continuing IVF therapy during the World Health Organization's (WHO) COVID-19 pandemic, except for necessary medical fertility preservation. However, the relaxation of COVID-19 limitations allowed IVF clinics and other healthcare facilities to reopen with precautions like ensuring adequate staff and adhering to appropriate safety procedures. In light of these elements, these factors aided in the market's quick recovery in the post-pandemic era.

Specimen Outlook

On the basis of specimen, the market is segmented into oocytes, embryos, and sperm. In 2022, the embryo segment acquired a substantial revenue share in the market. Extra embryos are vitrified to preserve them. IVF practitioners transfer fewer fresh embryos into the uterus to reduce the chance of multiple pregnancies. A frozen embryo transfer may be performed if the first cycle is unsuccessful rather than going through the inconveniences of ovarian stimulation and egg retrieval again.

Oocytes Outlook

The oocytes segment is further subdivided into devices and kits & consumables. The kits and consumables segment procured a significant revenue share in the market in 2022. The success of oocyte vitrification in fertility preservation and ART depends on the quality of the materials and procedures used. Vitrification kits and consumables contribute significantly to the overall success rate of the technique, ensuring that oocytes are preserved with high viability and developmental potential.

Embryo Outlook

The embryo segment is further bifurcated into devices and kits & consumables. The devices segment acquired the largest revenue share in the market in 2022. Vitrification devices, such as straws, vials, or specialized containers, serve as protective enclosures for embryos. They keep embryos securely contained during the vitrification process, preventing direct exposure to cryoprotectant solutions and minimizing the risk of physical damage. Devices are engineered to hold specific volumes of vitrification solutions and embryos.

End Use Outlook

Based on end-use, the market is fragmented into IVF clinics and biobanks. In 2022, the IVF clinics segment witnessed the largest revenue share in the market. The significant revenue share may result from the growing number of IVF clinics that provide vitrification and other ART services. Furthermore, the clinics are providing services like sperm, egg, and oocyte storage, which is anticipated to increase the income share of clinics. Regarding the IVF progress rate and the number of freezing cycles for oocytes and embryos, the vitrification technique considerably enhances the reproductive health environment.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the Europe region led the market by generating the largest revenue share. The existence of developed economies like those of France, Spain, Germany, the UK, and Italy is responsible for this. Because of the developed infrastructure in these nations, cryopreservation techniques are expected to increase dramatically in the region. Furthermore, the biotechnology sector's expansion and financial support for the development of assisted reproductive technologies in nations like the UK and Germany contribute to market growth. The high incidence of infertility and rising interest among women in egg preservation are the main drivers of regional development.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Vitrolife AB, Genea Limited (Liverpool Partners Group), NidaCon International AB, Minitub GmbH, Cryo Bio System (IMV Technologies Group), CooperSurgical Fertility & Genomic Solutions (The Cooper Companies, Inc.), FUJIFILM Irvine Scientific, Inc. (Fujifilm Holdings Corporation), Biotech, Inc., Kitazato Corporation and Shenzhen VitaVitro Biotech

Scope of the Study

Market Segments covered in the Report:

By Specimen

  • Oocytes
    • Devices
    • Kits & Consumables
  • Embryo
    • Devices
    • Kits & Consumables
  • Sperm

By End-use

  • IVF Clinics
  • Biobanks

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Vitrolife AB
  • Genea Limited (Liverpool Partners Group)
  • NidaCon International AB
  • Minitub GmbH
  • Cryo Bio System (IMV Technologies Group)
  • CooperSurgical Fertility & Genomic Solutions (The Cooper Companies, Inc.)
  • FUJIFILM Irvine Scientific, Inc. (Fujifilm Holdings Corporation)
  • Biotech, Inc.
  • Kitazato Corporation
  • Shenzhen VitaVitro Biotech

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Vitrification Market, by Specimen
    • 1.4.2 Global Vitrification Market, by End-use
    • 1.4.3 Global Vitrification Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market At a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
  • 3.3 Porter Five Forces Analysis

Chapter 4. Global Vitrification Market, By Specimen

  • 4.1 Global Oocytes Market, By Region
  • 4.2 Global Vitrification Market, By Oocytes Type
    • 4.2.1 Global Devices Market, By Region
    • 4.2.2 Global Kits & Consumables Market, By Region
  • 4.3 Global Embryo Market, By Region
  • 4.4 Global Vitrification Market, By Embryo Type
    • 4.4.1 Global Devices Market, By Region
    • 4.4.2 Global Kits & Consumables Market, By Region
  • 4.5 Global Sperm Market, By Region

Chapter 5. Global Vitrification Market, By End-use

  • 5.1 Global IVF Clinics Market, By Region
  • 5.2 Global Biobanks Market, By Region

Chapter 6. Global Vitrification Market, By Region

  • 6.1 North America Vitrification Market
    • 6.1.1 North America Vitrification Market, By Specimen
      • 6.1.1.1 North America Oocytes Market, By Country
      • 6.1.1.2 North America Vitrification Market, By Oocytes Type
        • 6.1.1.2.1 North America Devices Market, By Country
        • 6.1.1.2.2 North America Kits & Consumables Market, By Country
      • 6.1.1.3 North America Embryo Market, By Country
      • 6.1.1.4 North America Vitrification Market, By Embryo Type
        • 6.1.1.4.1 North America Devices Market, By Country
        • 6.1.1.4.2 North America Kits & Consumables Market, By Country
      • 6.1.1.5 North America Sperm Market, By Country
    • 6.1.2 North America Vitrification Market, By End-use
      • 6.1.2.1 North America IVF Clinics Market, By Country
      • 6.1.2.2 North America Biobanks Market, By Country
    • 6.1.3 North America Vitrification Market, By Country
      • 6.1.3.1 US Vitrification Market
        • 6.1.3.1.1 US Vitrification Market, By Specimen
        • 6.1.3.1.2 US Vitrification Market, By End-use
      • 6.1.3.2 Canada Vitrification Market
        • 6.1.3.2.1 Canada Vitrification Market, By Specimen
        • 6.1.3.2.2 Canada Vitrification Market, By End-use
      • 6.1.3.3 Mexico Vitrification Market
        • 6.1.3.3.1 Mexico Vitrification Market, By Specimen
        • 6.1.3.3.2 Mexico Vitrification Market, By End-use
      • 6.1.3.4 Rest of North America Vitrification Market
        • 6.1.3.4.1 Rest of North America Vitrification Market, By Specimen
        • 6.1.3.4.2 Rest of North America Vitrification Market, By End-use
  • 6.2 Europe Vitrification Market
    • 6.2.1 Europe Vitrification Market, By Specimen
      • 6.2.1.1 Europe Oocytes Market, By Country
      • 6.2.1.2 Europe Vitrification Market, By Oocytes Type
        • 6.2.1.2.1 Europe Devices Market, By Country
        • 6.2.1.2.2 Europe Kits & Consumables Market, By Country
      • 6.2.1.3 Europe Embryo Market, By Country
      • 6.2.1.4 Europe Vitrification Market, By Embryo Type
        • 6.2.1.4.1 Europe Devices Market, By Country
        • 6.2.1.4.2 Europe Kits & Consumables Market, By Country
      • 6.2.1.5 Europe Sperm Market, By Country
    • 6.2.2 Europe Vitrification Market, By End-use
      • 6.2.2.1 Europe IVF Clinics Market, By Country
      • 6.2.2.2 Europe Biobanks Market, By Country
    • 6.2.3 Europe Vitrification Market, By Country
      • 6.2.3.1 Germany Vitrification Market
        • 6.2.3.1.1 Germany Vitrification Market, By Specimen
        • 6.2.3.1.2 Germany Vitrification Market, By End-use
      • 6.2.3.2 UK Vitrification Market
        • 6.2.3.2.1 UK Vitrification Market, By Specimen
        • 6.2.3.2.2 UK Vitrification Market, By End-use
      • 6.2.3.3 France Vitrification Market
        • 6.2.3.3.1 France Vitrification Market, By Specimen
        • 6.2.3.3.2 France Vitrification Market, By End-use
      • 6.2.3.4 Russia Vitrification Market
        • 6.2.3.4.1 Russia Vitrification Market, By Specimen
        • 6.2.3.4.2 Russia Vitrification Market, By End-use
      • 6.2.3.5 Spain Vitrification Market
        • 6.2.3.5.1 Spain Vitrification Market, By Specimen
        • 6.2.3.5.2 Spain Vitrification Market, By End-use
      • 6.2.3.6 Italy Vitrification Market
        • 6.2.3.6.1 Italy Vitrification Market, By Specimen
        • 6.2.3.6.2 Italy Vitrification Market, By End-use
      • 6.2.3.7 Rest of Europe Vitrification Market
        • 6.2.3.7.1 Rest of Europe Vitrification Market, By Specimen
        • 6.2.3.7.2 Rest of Europe Vitrification Market, By End-use
  • 6.3 Asia Pacific Vitrification Market
    • 6.3.1 Asia Pacific Vitrification Market, By Specimen
      • 6.3.1.1 Asia Pacific Oocytes Market, By Country
      • 6.3.1.2 Asia Pacific Vitrification Market, By Oocytes Type
        • 6.3.1.2.1 Asia Pacific Devices Market, By Country
        • 6.3.1.2.2 Asia Pacific Kits & Consumables Market, By Country
      • 6.3.1.3 Asia Pacific Embryo Market, By Country
      • 6.3.1.4 Asia Pacific Vitrification Market, By Embryo Type
        • 6.3.1.4.1 Asia Pacific Devices Market, By Country
        • 6.3.1.4.2 Asia Pacific Kits & Consumables Market, By Country
      • 6.3.1.5 Asia Pacific Sperm Market, By Country
    • 6.3.2 Asia Pacific Vitrification Market, By End-use
      • 6.3.2.1 Asia Pacific IVF Clinics Market, By Country
      • 6.3.2.2 Asia Pacific Biobanks Market, By Country
    • 6.3.3 Asia Pacific Vitrification Market, By Country
      • 6.3.3.1 China Vitrification Market
        • 6.3.3.1.1 China Vitrification Market, By Specimen
        • 6.3.3.1.2 China Vitrification Market, By End-use
      • 6.3.3.2 Japan Vitrification Market
        • 6.3.3.2.1 Japan Vitrification Market, By Specimen
        • 6.3.3.2.2 Japan Vitrification Market, By End-use
      • 6.3.3.3 India Vitrification Market
        • 6.3.3.3.1 India Vitrification Market, By Specimen
        • 6.3.3.3.2 India Vitrification Market, By End-use
      • 6.3.3.4 South Korea Vitrification Market
        • 6.3.3.4.1 South Korea Vitrification Market, By Specimen
        • 6.3.3.4.2 South Korea Vitrification Market, By End-use
      • 6.3.3.5 Singapore Vitrification Market
        • 6.3.3.5.1 Singapore Vitrification Market, By Specimen
        • 6.3.3.5.2 Singapore Vitrification Market, By End-use
      • 6.3.3.6 Malaysia Vitrification Market
        • 6.3.3.6.1 Malaysia Vitrification Market, By Specimen
        • 6.3.3.6.2 Malaysia Vitrification Market, By End-use
      • 6.3.3.7 Rest of Asia Pacific Vitrification Market
        • 6.3.3.7.1 Rest of Asia Pacific Vitrification Market, By Specimen
        • 6.3.3.7.2 Rest of Asia Pacific Vitrification Market, By End-use
  • 6.4 LAMEA Vitrification Market
    • 6.4.1 LAMEA Vitrification Market, By Specimen
      • 6.4.1.1 LAMEA Oocytes Market, By Country
      • 6.4.1.2 LAMEA Vitrification Market, By Oocytes Type
        • 6.4.1.2.1 LAMEA Devices Market, By Country
        • 6.4.1.2.2 LAMEA Kits & Consumables Market, By Country
      • 6.4.1.3 LAMEA Embryo Market, By Country
      • 6.4.1.4 LAMEA Vitrification Market, By Embryo Type
        • 6.4.1.4.1 LAMEA Devices Market, By Country
        • 6.4.1.4.2 LAMEA Kits & Consumables Market, By Country
      • 6.4.1.5 LAMEA Sperm Market, By Country
    • 6.4.2 LAMEA Vitrification Market, By End-use
      • 6.4.2.1 LAMEA IVF Clinics Market, By Country
      • 6.4.2.2 LAMEA Biobanks Market, By Country
    • 6.4.3 LAMEA Vitrification Market, By Country
      • 6.4.3.1 Brazil Vitrification Market
        • 6.4.3.1.1 Brazil Vitrification Market, By Specimen
        • 6.4.3.1.2 Brazil Vitrification Market, By End-use
      • 6.4.3.2 Argentina Vitrification Market
        • 6.4.3.2.1 Argentina Vitrification Market, By Specimen
        • 6.4.3.2.2 Argentina Vitrification Market, By End-use
      • 6.4.3.3 UAE Vitrification Market
        • 6.4.3.3.1 UAE Vitrification Market, By Specimen
        • 6.4.3.3.2 UAE Vitrification Market, By End-use
      • 6.4.3.4 Saudi Arabia Vitrification Market
        • 6.4.3.4.1 Saudi Arabia Vitrification Market, By Specimen
        • 6.4.3.4.2 Saudi Arabia Vitrification Market, By End-use
      • 6.4.3.5 South Africa Vitrification Market
        • 6.4.3.5.1 South Africa Vitrification Market, By Specimen
        • 6.4.3.5.2 South Africa Vitrification Market, By End-use
      • 6.4.3.6 Nigeria Vitrification Market
        • 6.4.3.6.1 Nigeria Vitrification Market, By Specimen
        • 6.4.3.6.2 Nigeria Vitrification Market, By End-use
      • 6.4.3.7 Rest of LAMEA Vitrification Market
        • 6.4.3.7.1 Rest of LAMEA Vitrification Market, By Specimen
        • 6.4.3.7.2 Rest of LAMEA Vitrification Market, By End-use

Chapter 7. Company Profiles

  • 7.1 Vitrolife AB
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental and Regional Analysis
    • 7.1.4 Research & Development Expenses
    • 7.1.5 SWOT Analysis
  • 7.2 Genea Limited (Liverpool Partners Group)
    • 7.2.1 Company Overview
    • 7.2.2 SWOT Analysis
  • 7.3 NidaCon International AB
    • 7.3.1 Company Overview
    • 7.3.2 SWOT Analysis
  • 7.4 Minitub GmbH
    • 7.4.1 Company Overview
    • 7.4.2 SWOT Analysis
  • 7.5 Cryo Bio System (IMV Technologies Group)
    • 7.5.1 Company Overview
    • 7.5.2 SWOT Analysis
  • 7.6 CooperSurgical Fertility & Genomic Solutions (The Cooper Companies, Inc.)
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expense
    • 7.6.5 Recent strategies and developments:
      • 7.6.5.1 Partnerships, Collaborations, and Agreements:
      • 7.6.5.2 Acquisition and Mergers:
    • 7.6.6 SWOT Analysis
  • 7.7 FUJIFILM Irvine Scientific, Inc. (Fujifilm Holdings Corporation)
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Segmental and Regional Analysis
    • 7.7.4 Research & Development Expenses
    • 7.7.5 Recent strategies and developments:
      • 7.7.5.1 Product Launches and Product Expansions:
      • 7.7.5.2 Acquisition and Mergers:
      • 7.7.5.3 Geographical Expansions:
    • 7.7.6 SWOT Analysis
  • 7.8 Biotech, Inc.
    • 7.8.1 Company Overview
    • 7.8.2 SWOT Analysis
  • 7.9 Kitazato Corporation
    • 7.9.1 Company Overview
    • 7.9.2 SWOT Analysis
  • 7.10. Shenzhen VitaVitro Biotech
    • 7.10.1 Company Overview
    • 7.10.2 SWOT Analysis

Chapter 8. Winning imperatives: